Skip to main content
. 2025 Apr 9;24(5):100967. doi: 10.1016/j.mcpro.2025.100967

Fig. 3.

Fig. 3

Comparison of the DSIgG Fc glycopeptide ratios.A–F, comparison of the DSIgG Fc glycopeptide ratios between mild/moderate and severe NPDR. A, IgG1 G1FN/G0FN; B, IgG1 G1FN/G1F; C, IgG1 G2F/G0F; D, IgG1 G2F/G1F; E, IgG2 G1F/G1; F, IgG2 G2F/G1F. A1–D1, comparison of the DSIgG Fc glycopeptide ratios between patients with or with out DME. A1, DSIgG1 G2F/G1F; B1, DSIgG2 G1FN/G0FN; C1, DSIgG2 G2F/G0F; D1, DSIgG2 G2F/G1F. ns, no significance; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001. The p-values were calculated by the two-sided Mann-Whitney U test.